CDKN2A and neoplasm: Upon further evaluation, 11 were excluded because the authors assessed p16 methylation using DNA from other than tumor tissues, 31 excluded because it could not permit the calculation of HR estimate owing to the insufficient data reported in these studies, 4 excluded because the data reported in them were overlapped with other studies, and 14 excluded because the assessment was conducted on blood carcinomas.